Company Tagline
Allosteric modulators for Human Health
Industry Category
Business Keywords
Company Description
Addex Therapeutics is a leading biotechnology research company focused on pioneering allosteric modulators for human health. Specializing in the development and potential commercialization of innovative, orally available small molecule drugs, Addex Therapeutics aims to address neurological disorders with groundbreaking therapeutic approaches.
Located at Chemin des Aulx 12, Case postale 68, Plan-Les-Ouates, Switzerland 1228 (Primary Address) and Chemin des Mines 9, Geneva, 1202, CH, Addex Therapeutics is dedicated to advancing its robust pipeline of allosteric modulators. These modulators offer significant advantages over conventional non-allosteric molecules, potentially providing improved treatments for conditions like Parkinson’s disease levodopa-induced dyskinesia (PD-LID), blepharospasm, epilepsy, and addiction. Addex Therapeutics' commitment to innovation extends to preclinical programs targeting CMT1A, PTSD, mild neurocognitive disorders, Parkinson’s disease, and neurodegenerative disorders.
With a strong foundation in allosteric modulation, Addex Therapeutics continues to explore and develop cutting-edge solutions for a range of critical health challenges. As a company listed on the SIX Swiss Exchange and NASDAQ Capital Market under the ticker symbol "ADXN", Addex Therapeutics is dedicated to improving patient outcomes through advanced pharmaceutical research and development. We invite the management team at Addex Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight your groundbreaking work.
Key Personnel / Employees
Compare Companies Side by Side
Compare Addex Therapeutics with 3 companies in Biotechnology-Research
| Comparison Field |
Addex TherapeuticsMain Company |
Personality Developm...View Profile |
Eating and Behaviora...View Profile |
MyogenesView Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2017 | 2018 | 2016 |
|
Company Size
|
— | 2-10 | 11-50 | 2-10 |
|
City
|
Plan-Les-Ouates, Switzerland | Jakarta Selatan, Jakarta | Columbus, Ohio | Elstree, Hertfordshire |
|
Country
|
Indonesia | United States | ||
|
Skills & Keywords
Comparing with main company
|
26 Total Skills
Allosteric Modulators
Neurological Disorders
Parkinson's Disease
Pharmaceutical Research
Drug Development
Biotechnology
mGlu Receptors
allosteric modulation
Parkinson's disease
schizophrenia
inflammation
metabolic
diabetes
dyskinesia
anxiety
pain
depression
PTSD
Alzheimer's
mGlu
mGluR
GABA
FSH
GLP-1
TNF
IL-1
|
12 Total
12 Unique
Unique Skills:
bipolar disorder
brain
cognitive behavior therapy
drugs addiction
human resources
mental health
+6
|
9 Total
9 Unique
Unique Skills:
body image
cognitive behavioral therapy
counseling
eating disorders
mental health
psychologist
+3
|
17 Total
17 Unique
Unique Skills:
ADHD
autism
bipolar disorder
BRCA
cancer risk
DNA testing
+11
|
4
Total Companies2016
Oldest Founded2
Countries61
Unique SkillsSimilar Companies
Other organizations in the same industry
NC BioNetwork
Biotechnology-ResearchThe life science training initiative of the North Carolina Community College System.
Biodiversity Biobanks South Africa (BBSA)
Biotechnology-ResearchA virtual network linking and guiding South Africa’s biodiversity biobanks
Orbone Cell and Tissue Bank
Biotechnology-ResearchHight Quality Allografts
biorevert Inc.
Biotechnology-ResearchReversionTherapeutics: We develop reversion therapeutic technologies to revert cancer and aging.
Alternative Company Names
This company is also known as